128 related articles for article (PubMed ID: 19713674)
1. Anti-atherosclerotic effects of dihomo-gamma-linolenic acid in ApoE-deficient mice.
Takai S; Jin D; Kawashima H; Kimura M; Shiraishi-Tateishi A; Tanaka T; Kakutani S; Tanaka K; Kiso Y; Miyazaki M
J Atheroscler Thromb; 2009 Aug; 16(4):480-9. PubMed ID: 19713674
[TBL] [Abstract][Full Text] [Related]
2. Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis.
Gallagher H; Williams JO; Ferekidis N; Ismail A; Chan YH; Michael DR; Guschina IA; Tyrrell VJ; O'Donnell VB; Harwood JL; Khozin-Goldberg I; Boussiba S; Ramji DP
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2538-2550. PubMed ID: 31202985
[TBL] [Abstract][Full Text] [Related]
3. Differential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2.
Levin G; Duffin KL; Obukowicz MG; Hummert SL; Fujiwara H; Needleman P; Raz A
Biochem J; 2002 Jul; 365(Pt 2):489-96. PubMed ID: 11939906
[TBL] [Abstract][Full Text] [Related]
4. A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in
Takagahara S; Shinohara H; Itokawa S; Satomi Y; Ando A; Yamamoto T; Suzuki H; Fujimoto T; Kubo K; Ikeda S
J Pharmacol Exp Ther; 2019 Nov; 371(2):290-298. PubMed ID: 31488602
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of whole dihomo-γ-linolenic acid-producing Saccharomyces cerevisiae suppresses cutaneous inflammatory responses induced by croton oil application in mice.
Watanabe N; Masubuchi D; Itoh M; Teradu S; Yazawa H; Uemura H
Appl Microbiol Biotechnol; 2014 Oct; 98(20):8697-706. PubMed ID: 25070596
[TBL] [Abstract][Full Text] [Related]
6. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases.
Wang X; Lin H; Gu Y
Lipids Health Dis; 2012 Feb; 11():25. PubMed ID: 22333072
[TBL] [Abstract][Full Text] [Related]
7. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice.
Matsumoto M; Sata M; Fukuda D; Tanaka K; Soma M; Hirata Y; Nagai R
Atherosclerosis; 2008 Apr; 197(2):524-33. PubMed ID: 17765904
[TBL] [Abstract][Full Text] [Related]
8. Anti-atherosclerotic effects of Polygonum aviculare L. ethanol extract in ApoE knock-out mice fed a Western diet mediated via the MAPK pathway.
Haeng Park S; Sung YY; Jin Nho K; Kyoung Kim H
J Ethnopharmacol; 2014 Feb; 151(3):1109-1115. PubMed ID: 24370878
[TBL] [Abstract][Full Text] [Related]
9. Distribution and metabolism of dihomo-gamma-linolenic acid (DGLA, 20:3n-6) by oral supplementation in rats.
Umeda-Sawada R; Fujiwara Y; Ushiyama I; Sagawa S; Morimitsu Y; Kawashima H; Ono Y; Kiso Y; Matsumoto A; Seyama Y
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2121-30. PubMed ID: 16960355
[TBL] [Abstract][Full Text] [Related]
10. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
[TBL] [Abstract][Full Text] [Related]
11. The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice.
Jacob S; Laury-Kleintop L; Lanza-Jacoby S
J Surg Res; 2008 May; 146(1):135-42. PubMed ID: 17950326
[TBL] [Abstract][Full Text] [Related]
12. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
[TBL] [Abstract][Full Text] [Related]
13. DGLA from the Microalga
Novichkova E; Chumin K; Eretz-Kdosha N; Boussiba S; Gopas J; Cohen G; Khozin-Goldberg I
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32971852
[TBL] [Abstract][Full Text] [Related]
14. Dihomo-γ-linolenic acid prevents the development of atopic dermatitis through prostaglandin D1 production in NC/Tnd mice.
Amagai Y; Oida K; Matsuda A; Jung K; Kakutani S; Tanaka T; Matsuda K; Jang H; Ahn G; Xia Y; Kawashima H; Shibata H; Matsuda H; Tanaka A
J Dermatol Sci; 2015 Jul; 79(1):30-7. PubMed ID: 25907057
[TBL] [Abstract][Full Text] [Related]
15. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
[TBL] [Abstract][Full Text] [Related]
16. Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet.
Stepankova R; Tonar Z; Bartova J; Nedorost L; Rossman P; Poledne R; Schwarzer M; Tlaskalova-Hogenova H
J Atheroscler Thromb; 2010 Aug; 17(8):796-804. PubMed ID: 20379054
[TBL] [Abstract][Full Text] [Related]
17. Sinigrin attenuates the progression of atherosclerosis in ApoE
Jang YJ; Park B; Lee HW; Park HJ; Koo HJ; Kim BO; Sohn EH; Um SH; Pyo S
Chem Biol Interact; 2017 Jun; 272():28-36. PubMed ID: 28483571
[TBL] [Abstract][Full Text] [Related]
18. Antiatherogenic effect of antioxidant polyphenols from Phellinus baumii in apolipoprotein E-deficient mice.
Noh JR; Lee IK; Kim YH; Gang GT; Hwang JH; Ly SY; Yun BS; Lee CH
Ann Nutr Metab; 2011; 59(2-4):145-53. PubMed ID: 22142871
[TBL] [Abstract][Full Text] [Related]
19. Dihomo-gamma-linolenic acid inhibits tumour necrosis factor-alpha production by human leucocytes independently of cyclooxygenase activity.
Dooper MM; van Riel B; Graus YM; M'Rabet L
Immunology; 2003 Nov; 110(3):348-57. PubMed ID: 14632663
[TBL] [Abstract][Full Text] [Related]
20. Flaxseed Oil Containing α -Linolenic Acid Ester of Plant Sterol Improved Atherosclerosis in ApoE Deficient Mice.
Han H; Yan P; Chen L; Luo C; Gao H; Deng Q; Zheng M; Shi Y; Liu L
Oxid Med Cell Longev; 2015; 2015():958217. PubMed ID: 26180602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
